Roskilde Festival unveils one of its 2017 headliners

American rock giants Foo Fighters will return to the Orange Stage next summer

Dave Grohl’s Foo Fighters will be among the headliners at the 2017 Roskilde Festival.

READ MORE: Yorke got to be kidding! Radiohead coming to Denmark

This will mark Grohl’s fourth trip to Roskilde. He first appeared as the drummer for Nirvana in 1992. He then returned to front the Foo Fighters in 1995, and again ten years later in 2005. The Foo Fighters were last in Denmark in 2011.

The band’s catalogue of gold and platinum albums has won 11 Grammys and four Brit Awards and pushed more than 25 million records over the counter.

Pigs not safe
The festival has also announced 15 other artists who will be part of the 2017 festivities, including G-Easy, Pig Destroyer and Moderat/Modeselektor.

Tickets for the 2017 Roskilde Festival go on sale on November 15.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.